The intrinsic advantages of circRNAs, including their covalently closed structure, which ensures remarkable stability in body fluids, further expand the clinical applicability of circ-PRMT1, enabling its use for noninvasive monitoring in colorectal adenocarcinoma, as previously reported for several other circRNAs [40]. The gene discussed is PRMT1; the disease is colorectal adenocarcinoma.